Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink
Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink
Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases | SpringerLink
PDF) Markers of increased cardiovascular risk in patients with chronic kidney disease
Beneficial activities of losmapimod in atherosclerosis. Abbreviation:... | Download Scientific Diagram
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation | Metabolic Syndrome and Related Disorders
Applied Sciences | Free Full-Text | Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication | HTML
JLA :: Journal of Lipid and Atherosclerosis
The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study | Journal of Translational Medicine | Full Text
Cells | Free Full-Text | Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease | HTML
PDF) The Role of Atherosclerotic Cardiovascular Risk Enhancers in the Prediction of Cardiovascular Events: Tehran Lipid and Glucose Study
PDF) Markers of Atherosclerosis: Part 1 – Serological Markers
Medical management of risk factors for vascular disease - ScienceDirect
Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. - Abstract - Europe PMC
Frontiers | Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases
PDF) Emerging Anti-Atherosclerotic Therapies
Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink
Breast Arterial Calcification: A Potential Biomarker for Atherosclerotic Cardiovascular Disease Risk? | SpringerLink
Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging | SpringerLink
Beneficial activities of losmapimod in atherosclerosis. Abbreviation:... | Download Scientific Diagram
Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study - ScienceDirect
The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study | Journal of Translational Medicine | Full Text
BIOMARKERS OF CARDIOVASCULAR DISEASE - Scherbak - Physical and rehabilitation medicine, medical rehabilitation
Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study | Scientific Reports
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting - ScienceDirect
